Michael Kiernan to Clinical Trials as Topic
This is a "connection" page, showing publications Michael Kiernan has written about Clinical Trials as Topic.
Connection Strength
0.249
-
Mahr C, Thinh Pham D, Mokadam NA, Silvestry SC, Cowger J, Kiernan MS, D'alessandro DA, Coglianese EE, Faraz Masood M, Kormos RL, Jacoski MV, Teuteberg JJ. Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population. ASAIO J. 2019 Mar-Apr; 65(3):293-296.
Score: 0.123
-
Kiernan MS, Sundareswaran KS, Pham DT, Kapur NK, Pereira NL, Strueber M, Farrar DJ, DeNofrio D, Rogers JG. Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. J Card Fail. 2016 Oct; 22(10):797-805.
Score: 0.099
-
Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, Fonarow GC, Greenberg B, Januzzi JL, Kiernan MS, Liu PP, Wang TJ, Yancy CW, Zile MR. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017 May 30; 135(22):e1054-e1091.
Score: 0.027